Ensuring Patients’ Access to High-Value Cancer Drugs
A new era of rapid scientific advancement in cancer research has led to the development of safe, effective, and potentially life-saving drugs for many patients who, until recently, had few treatment options. As our understanding of molecular drivers of cancer has expanded, so have opportunities to develop better and more-targeted drugs. However, there is much potential for making the established methods used to evaluate these innovative therapies more efficient, potentially contributing to more affordable drugs for patients. The time is now for all constituencies involved in research and development to re-assess current processes and consider new practices to streamline drug development. The goal: ensure timely access to cost-effective drugs for all cancer patients while stimulating innovation.